safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-cisplatin in patients with advanced cancer的安全性和药物动力学motesanib结合帕尼单抗和gemcitabine-cisplatin晚期癌症患者.pdfVIP

  • 0
  • 0
  • 约8.69万字
  • 约 12页
  • 2017-08-29 发布于上海
  • 举报

safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-cisplatin in patients with advanced cancer的安全性和药物动力学motesanib结合帕尼单抗和gemcitabine-cisplatin晚期癌症患者.pdf

safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-cisplatin in patients with advanced cancer的安全性和药物动力学motesanib结合帕尼单抗和gemcitabine-cisplatin晚期癌症患者

Hindawi Publishing Corporation Journal of Oncology Volume 2011, Article ID 853931, 11 pages doi:10.1155/2011/853931 Research Article Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer Howard Burris,1 Joe Stephenson,2 Gregory A. Otterson,3 Mark Stein,4 Jesse McGreivy,5 Yu-Nien Sun,5 Megan Ingram,6 Yining Ye,6 and Lee S. Schwartzberg7 1 Sarah Cannon Research Institute, Nashville, TN 37203, USA 2 Cancer Center of t

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档